Considering that IGF-1 administration to patients with diabetes improves diabetes control, by increasing insulin sensitivity and decreasing secondary GH resistance, Laron and Weinberger have speculated that IGF-1 has a ‘permissive’ mediating or even a ‘protective’ role in the development of diabetic retinopathy.12 The gene discussed is IGF1; the disease is diabetic retinopathy.